Overview

This trial is active, not recruiting.

Condition obesity
Treatments web-based lifestyle modification, web-based lifestyle modification +
Sponsor Clínica Bazterrica
Start date August 2012
End date August 2013
Trial size 350 participants
Trial identifier NCT01664026, PWeb123

Summary

To evaluate the effect of a 6-month web-based lifestyle modification program with and without telephone counseling versus usual care in obese patients with cardiovascular risk factors on:

- Weight Loss

- Waist circumference; blood pressure; total cholesterol, triglycerides, LDL-cholesterol, HDL-cholesterol; glucose and hemoglobin A1c; C-reactive protein.

- Physical activity and eating habits

- Quality of life

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Allocation randomized
Endpoint classification efficacy study
Intervention model parallel assignment
Masking open label
Primary purpose prevention
Arm
(No Intervention)
Subjects assigned to the usual care group will receive general lifestyle recommendations as per their country standards of care.
(Experimental)
Access to a web-based lifestyle modification program of 6-month duration that covers all aspects of a healthy lifestyle including physical activity, nutrition and weight maintenance.
web-based lifestyle modification
Access to a web-based lifestyle modification program of 6-month duration that covers all aspects of a healthy lifestyle including physical activity, nutrition and weight maintenance.
(Experimental)
Access to a web-based lifestyle modification program of 6-month duration that covers all aspects of a healthy lifestyle including physical activity, nutrition and weight maintenance plus telephone counseling support by health coaches on a weekly or bi-weekly basis.
web-based lifestyle modification +
Access to a web-based lifestyle modification program of 6-month duration that covers all aspects of a healthy lifestyle including physical activity, nutrition and weight maintenance plus telephone counseling support by health coaches on a weekly or bi-weekly basis.

Primary Outcomes

Measure
Change in body weight from randomization to 6 months
time frame: 6 months

Secondary Outcomes

Measure
Changes in waist circumference
time frame: 6 months
Changes in blood pressure
time frame: 6 months
Changes in lipid parameters (total cholesterol, triglycerides, LDL-cholesterol, HDL-cholesterol)
time frame: 6 months
Changes in glycemic parameters (glucose and hemoglobin A1c)
time frame: 6 months
Changes in C-reactive protein
time frame: 6 months

Eligibility Criteria

Male or female participants from 25 years up to 70 years old.

Inclusion Criteria: 1. Male or female 25-70 years of age 2. Obese (BMI ≥ 30 kg/m2 and <40 kg/m2) 3. At least 2 cardiovascular risk factors (diabetes, hypertension or dyslipidemia) i) Hypertension defined by a history of hypertension, treatment of hypertension or BP values >140/90 mmHg in two consecutive office visits ii) High cholesterol defined by an LDL-C ≥130 mg/dL and/or HDL-C <40 mg/dL and triglycerides ≥150 mg/dL iii) Type 2 Diabetes Mellitus defined by a history of diabetes, treatment of diabetes or fasting glucose ≥126 mg/dL in two consecutive office visits 4. Participant must be willing and able to provide written informed consent 5. Participant must be willing and able to comply with study related procedures 6. Participant must have access to Internet and e-mail Exclusion Criteria: 1. Stage 1 or 2 on Patient Activation Measures tool 2. Weight change of more than 5 kg during the 3 months preceding the screening visit 3. History of bariatric surgery 4. Fasting Plasma Glucose at screening > 250 mg/dL (> 13.9 mmol/L) 5. Hemoglobin A1c at screening >8.5% 6. Treatment of type 2 diabetes with insulin (except for history of intermittent acute use, no more than 2 weeks usage in previous 6 months) 7. Uncontrolled or inadequately controlled hypertension at the time of screening with blood pressure >160/100 mmHg 8. Secondary hypertension 9. Changes in lipid, blood pressure or diabetes modifying agents including introduction, change in dose or cessation in the 3 months prior to Screening Visit 10. Personal history of coronary heart disease, congestive heart failure, serious arrhythmias and stroke 11. Cardiovascular, hepatic, neurological, endocrine disease, active malignant tumor or other major systemic disease making implementation of the protocol or interpretation of the study results difficult. 12. Presence of any condition (medical, psychological, social, or geographical), actual or anticipated, that in the opinion of the Investigator would restrict or limit the patient's successful participation for the duration of the study 13. Presence of history of cancer within the past five years with the exception of adequately treated localized basal cell skin cancer or in situ uterine cervical cancer 14. Use of systemic glucocorticoids (excluding topical application or inhaled forms) for one week or more within 3 months prior to the time of screening 15. Use of any investigational agent (drug, biologic, device) within 3 months prior to screening

Additional Information

Official title A 6-Month, Randomized Study to Evaluate the Efficacy of a Web-based Lifestyle Modification Program With and Without Telephone Counseling Support
Trial information was received from ClinicalTrials.gov and was last updated in August 2012.
Information provided to ClinicalTrials.gov by Clínica Bazterrica.